Neutrolis
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Phone Number
(617) 863-3650Website
www.neutrolis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Neutrolis
Neutrolis is a clinical stage company focused on developing first-in-class precision therapies for autoimmune and inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs). Their innovative exDNASE platform is designed to disassemble harmful NETs, addressing the root causes of immune-mediated disorders rather than just alleviating symptoms. Neutrolis aims to revolutionize treatment in this field and improve the lives of millions of patients globally. The company is committed to advancing translational medicine and enhancing the understanding of NETosis.Explore more
Neutrolis Org Chart
TF
Co-Founder, Co-President & CSO
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neutrolis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Neutrolis
Check out if Neutrolis is spiking on competitors!
Funding: Get notified immidiatlly once Neutrolis has new funding data
Website visits: Recent activity has been detected on your website
Check if Neutrolis has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Neutrolis recently announced quarterly report
Click to see if Neutrolis had a recent Job posting/layoffs
Product Launch: Get notified when Neutrolis launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Neutrolis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Neutrolis as Masked Content
Find more new buyers
Compare Similar Companies to Neutrolis
Compare insights from companies similar to Neutrolis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Neutrolis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Neutrolis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Neutrolis.
Neutrolis financials insights
Gather financial insights about Neutrolis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$81K
Neutrolis Tech Stack
A closer look at the technologies used by Neutrolis
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
Neutrolis has announced that Anthony Aiudi has been promoted to the role of Chief Executive Officer.
New Hire
Executive Move
Neutrolis has announced that Ralph Lambalot has joined the organization as Chief Technology Officer.
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Neutrolis
Sign Up For FreeTo access detailed company insights
Neutrolis is a clinical stage company focused on developing first-in-class precision therapies for autoimmune and inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs). Their innovative exDNASE platform is designed to disassemble harmful NETs, addressing the root causes of immune-mediated disorders rather than just alleviating sy... Read More
